atpa

ATPA is a selective glutamate receptor GluR5 activator (EC50s: 0.66, 1.4, 9.5, 23, 32, 18, and 14 μM for GluR5wt, GluR5(S721T), GluR5(S741M), GluR5(S721T, S741M), GluR5(S741A), GluR5(S741L), and GluR5(S741V)).

8-[(2,6-dimethylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-car is a H+ K+ ATPase inhibitor with IC50 of 0.38μM.

V-ATPase-IN-1 (Compound 3b-03) is an inhibitor of Vacuolar-type H+-ATPases (V-ATPase), exhibiting an inhibition constant (IC50) of 194.80 μM and effectively targeting the V-ATPase subunit A with a dissociation constant (Kd) of 0.803 μM. This compound demonstrates insecticidal activity against M. separata (LC50 = 2.64 mM), aiding in the development of chemical insecticides.

ATPase-IN-5 (compound 11) is an effective inhibitor of Pma1p-ATPase, with an IC50 value of 12.7 μM. It plays a significant role in antifungal research.

ATPase-IN-2 is a compound that acts as an inhibitor of ATPase, with an IC50 value of 0.9 μM. It also inhibits the glycohydrolase activity of C. difficile toxin B (TcdB) with an AC50 value of 30.91 μM. ATPase-IN-2 is commonly utilized in ATP-related research [1].

ATPase-IN-3 is an ATPase (ATPase) inhibitor that can be used in the study of metabolism-related diseases.

Compound MS1 (ATPase-IN-4) effectively inhibits the ATPase activity of EHD4, demonstrating an IC 50 of 0.92 μM. It also suppresses the enzymatic activity of EHD2.

RUVBL1 2 ATPase-IN-1 is an effective RUVBL1 2 ATPase inhibitor with IC50 values of 6.0 and 7.7 μM, respectively. RUVBL1 2 ATPase-IN-1 can be used in cancer disease studies.